Philip Kletnieks Email

Senior Director . InCarda Therapeutics

Current Roles

Employees:
21
Revenue:
$1.6M
About
InCarda Therapeutics is a clinical stage drug delivery company pioneering a novel approach of treating cardiovascular diseases and conditions by the inhalation route. The lead product under development is an inhaled therapy to treat a common atrial arrhythmia, paroxysmal atrial fibrillation (PAF).
InCarda Therapeutics Address
39899 Balentine Dr
Newark, CA
United States
InCarda Therapeutics Email

Past Companies

Revagenix, Inc.Senior Director, Analytical Chemistry
Philip Kletnieks Consulting, LLCPharmaceutical Development Consultant
InCarda TherapeuticsSenior Director

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.